Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Medical Research Council Population Health Research Unit (MRC PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
J Epidemiol Community Health. 2018 Oct;72(10):919-925. doi: 10.1136/jech-2018-210651. Epub 2018 Jul 3.
Diabetes is associated with higher risk of colorectal cancer (CRC). Uncertainty remains about the relevance of duration of diabetes and about the association of blood glucose with CRC risk among individuals without diabetes.
The prospective China Kadoorie Biobank recruited 512 713 participants in 2004-2008 from 10 diverse areas in China. After 10 years of follow-up, 3024 incident cases of CRC (1745 colon, 1716 rectal) were recorded among 510 136 participants without prior cancer at baseline. Cox regression was used to estimate adjusted HRs for CRC associated with diabetes (previously diagnosed or screen-detected) and, among those without previously diagnosed diabetes, with levels of random plasma glucose (RPG).
Overall 5.8% of participants had diabetes at baseline. Individuals with diabetes had an adjusted HR of 1.18 (95% CI 1.04 to 1.33) for CRC, with similar risk for colon and rectal cancer (1.19 [1.01 to 1.39] vs 1.14 [0.96 to 1.35]). The HRs decreased with longer duration of diabetes ( for trend 0.03). Among those without previously diagnosed diabetes, RPG was positively associated with CRC, with adjusted HRs per 1 mmol/L higher baseline RPG of 1.04 (1.02 to 1.05) for CRC, again similar for colon and rectal cancer (1.03 [1.01to 1.05] and 1.04 [1.02 to 1.06], respectively). The associations of diabetes and RPG appeared stronger in men than in women, but the differences were non-significant ( for heterogeneity 0.3 and 0.2).
Among Chinese adults, diabetes and higher blood glucose levels among those without known diabetes are associated with higher risk of CRC.
糖尿病与结直肠癌(CRC)的风险升高相关。糖尿病病程长短与无糖尿病个体的血糖水平与 CRC 风险之间的相关性仍存在不确定性。
前瞻性的中国慢性病前瞻性研究于 2004-2008 年在中国 10 个不同地区招募了 512713 名参与者。在 10 年的随访后,在 510136 名基线时无癌症的参与者中记录了 3024 例 CRC(1745 例结肠癌,1716 例直肠癌)的发病情况。Cox 回归用于估计与糖尿病(已确诊或筛查发现)相关的 CRC 的调整后 HR,并在那些无先前诊断为糖尿病的患者中,估计与随机血浆葡萄糖(RPG)水平相关的 CRC 的 HR。
总体而言,5.8%的参与者基线时有糖尿病。患有糖尿病的个体发生 CRC 的调整后 HR 为 1.18(95%CI 1.04 至 1.33),结肠癌和直肠癌的风险相似(1.19[1.01 至 1.39] 与 1.14[0.96 至 1.35])。随着糖尿病病程的延长,HR 降低(趋势检验 P=0.03)。在那些无先前诊断为糖尿病的患者中,RPG 与 CRC 呈正相关,基线 RPG 每升高 1mmol/L,CRC 的调整后 HR 为 1.04(1.02 至 1.05),结肠癌和直肠癌的风险也相似(1.03[1.01 至 1.05] 和 1.04[1.02 至 1.06])。糖尿病和 RPG 与 CRC 的关联在男性中比在女性中更强,但差异无统计学意义(异质性检验 P=0.3 和 0.2)。
在中国成年人中,糖尿病和无已知糖尿病个体的较高血糖水平与 CRC 风险升高相关。